ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Consistent with this, hepatic messenger RNA and circulating levels of different cytokines were increased, whereas adiponectin (a positive marker of insulin sensitivity) was decreased in NAFLD/NASH (Fig. 2a,c).